Tri-legest Fe Kit
Product Images NDC 0555-9032

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Tri-legest Fe (NDC 0555-9032). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure diagram of Norethindrone Acetate and Ethinyl Estradiol, the active ingredients in Tri-Legest Fe 28 Day by Teva Pharmaceuticals USA, Inc.*

FDA Label Image

Tri-legest Fe (norethindrone Acetate And Ethinyl Estradiol Tablets, Usp And Ferrous Fumarate Tablets*) Carton, Part 1 Of 2 (Image 10)

An instructional diagram illustrating how to use the Tri-Legest Fe 28 Day kit, showing a 28-pill blister card layout. The diagram instructs users to start with the Sunday starters and Day-1 starters, explaining how to apply the day of the week sticker to align with the first day of the menstrual period. It guides users to take pills from left to right, with arrows indicating the pill-taking direction.*

FDA Label Image

Tri-legest Fe (norethindrone Acetate And Ethinyl Estradiol Tablets, Usp And Ferrous Fumarate Tablets*) Carton, Part 2 Of 2 (Image 11)

Packaging label for Tri-Legest Fe, a kit of norethindrone acetate and ethinyl estradiol tablets, including ferrous fumarate tablets. The label shows a 28-day regimen with five tablet dispensers each containing 28 tablets. It includes storage instructions and warnings, the Teva Pharmaceuticals USA, Inc. logo, and the NDC 0555-9032-70.*

FDA Label Image

Image 12

Packaging label for Tri-Legest Fe 28 Day Kit by Teva Pharmaceuticals USA, Inc., containing norethindrone acetate and ethinyl estradiol tablets with ferrous fumarate tablets. The kit includes five tablet dispensers, each with 28 tablets, as part of a 28-day regimen. The label features drug details, handling instructions, and barcodes.*

FDA Label Image

Image 2

Chemical structure diagram of the active ingredient Norethindrone Acetate. The image shows its steroid skeleton with acetate and ethynyl functional groups.*

FDA Label Image

Image 3

Two line graphs showing the mean plasma concentrations of Ethinyl Estradiol and Norethindrone over 24 hours. The first graph plots Ethinyl Estradiol concentration (pg/mL) against time (hours), and the second graph shows Norethindrone concentration (ng/mL) versus time (hours). Different symbols represent doses: 1/20, 1/30, and 1/35.*

FDA Label Image

Image 4

A line graph comparing mean percent reduction in total lesion counts over six treatment cycles between norethindrone acetate and ethinyl estradiol tablets versus placebo in an intent-to-treat population. The chart includes a legend distinguishing treatment groups and numerical lesion counts below the x-axis for each cycle.*

FDA Label Image

Image 5

A bar chart depicting mortality rates per 100,000 women users by age group and smoking status, comparing ever-users and controls across age ranges 15-24, 25-34, 35-44, and 45 and older. The chart includes categories for non-smokers and smokers within ever-users and controls.*

FDA Label Image

Image 6

A forest plot chart showing effect estimates (odds ratios or relative risks) with confidence intervals from various studies on contraceptive use. Studies include NICHD Women's Contraceptive Study 2002, French E3N cohort Study 2005, Shanghai Women's Health Study 2009, Nurses' Health Study II 2010, Oxford Family Planning Association Study 2013, and Danish Sex Hormone Register Study 2017, with comparisons for ever use and current use, plotted along a horizontal axis ranging from -1.5 to 2.0.*

FDA Label Image

Image 7

An instructional diagram for Tri-Legest Fe 28 Day oral contraceptive kit showing the pill pack layout with 21 pill positions arranged in rows labeled by days of the week. The diagram includes guidance to start on Sunday or Day 1 of the menstrual cycle, directions to place the day sticker starting with the first day of the period, and arrows indicating to take pills from left to right.*

FDA Label Image

Image 8

An instructional diagram for the Tri-Legest Fe 28 Day kit showing a drug blister pack layout. It includes guidance on starting the medication depending on the day your period begins, highlighting Sunday starters and Day-1 starters. Arrows indicate taking pills from left to right across the pack.*

FDA Label Image

Image 9

An instructional diagram for a Tri-Legest Fe 28 Day pill kit showing a weekly pill organizer with circles representing pills labeled by days of the week. It includes directions to start on Sunday or Day-1 starters, guidance for days other than Sunday, and arrows indicating to take pills from left to right.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.